Birdwatch Note
2025-01-10 04:49:06 UTC - NOT_MISLEADING
NNN The proposed note says Gibson’s experience is baseless, which is easily verifiably false. It also implies one medicine can’t have different side effects or severity in different people, which is ludicrous. https://www.science.org/content/article/very-very-bad-look-remdesivir-first-fda-approved-covid-19-drug
Written by 1303E5018D829FD7242E676513140391EA7B5782749F9031CB0658FF1C74D82F
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1877527505919173081
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1877578389902573845
- noteId - 1877578389902573845
- participantId -
- noteAuthorParticipantId - 1303E5018D829FD7242E676513140391EA7B5782749F9031CB0658FF1C74D82F
- createdAtMillis - 1736484546530
- tweetId - 1877527505919173081
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 1
- trustworthySources - 1
- summary
- NNN The proposed note says Gibson’s experience is baseless, which is easily verifiably false. It also implies one medicine can’t have different side effects or severity in different people, which is ludicrous. https://www.science.org/content/article/very-very-bad-look-remdesivir-first-fda-approved-covid-19-drug
Note Ratings
| rated at | rated by | |
| 2025-01-10 18:12:18 -0600 | Rating Details | |
| 2025-01-10 17:46:28 -0600 | Rating Details | |
| 2025-01-10 14:40:50 -0600 | Rating Details | |
| 2025-01-10 13:31:03 -0600 | Rating Details | |
| 2025-01-10 12:25:15 -0600 | Rating Details | |
| 2025-01-10 08:59:08 -0600 | Rating Details | |
| 2025-01-10 05:25:06 -0600 | Rating Details | |
| 2025-01-10 04:31:49 -0600 | Rating Details | |
| 2025-01-10 03:19:28 -0600 | Rating Details | |
| 2025-01-10 02:25:40 -0600 | Rating Details | |
| 2025-01-10 01:26:43 -0600 | Rating Details | |
| 2025-01-10 01:06:44 -0600 | Rating Details | |
| 2025-01-10 00:53:01 -0600 | Rating Details | |
| 2025-01-10 00:25:37 -0600 | Rating Details | |
| 2025-01-09 23:28:02 -0600 | Rating Details | |
| 2025-01-09 23:12:24 -0600 | Rating Details | |
| 2025-01-10 16:41:23 -0600 | Rating Details | |
| 2025-01-10 13:44:21 -0600 | Rating Details | |
| 2025-01-10 10:14:56 -0600 | Rating Details | |
| 2025-01-10 05:47:04 -0600 | Rating Details | |
| 2025-01-10 04:07:13 -0600 | Rating Details | |
| 2025-01-10 03:10:00 -0600 | Rating Details | |
| 2025-01-10 02:41:59 -0600 | Rating Details | |
| 2025-01-14 20:29:06 -0600 | Rating Details | |
| 2025-01-10 22:14:43 -0600 | Rating Details | |
| 2025-01-10 04:33:05 -0600 | Rating Details | |
| 2025-01-10 03:25:33 -0600 | Rating Details | |
| 2025-01-10 15:10:05 -0600 | Rating Details | |
| 2025-01-10 13:57:30 -0600 | Rating Details | |
| 2025-01-10 11:37:19 -0600 | Rating Details | |
| 2025-01-10 10:36:35 -0600 | Rating Details | |
| 2025-01-10 01:47:04 -0600 | Rating Details | |
| 2025-01-09 23:47:01 -0600 | Rating Details |